Pioneering colorectal cancer screening: blood-based DNA tests as a global strategy for early detection - editorial.
作者信息
Yogi Tek Nath, Bhusal Amrit, Dulal Soniya, Sharma Rajeev, Rauniyar Krish
机构信息
Department of Surgery; BP Koirala Institute of Health Sciences (BPKIHS).
Department of Internal Medicine; BP Koirala Institute of Health Sciences (BPKIHS).
出版信息
Int J Surg. 2024 Nov 1;110(11):6906-6910. doi: 10.1097/JS9.0000000000001964.
Abstract
摘要
相似文献
1
Pioneering colorectal cancer screening: blood-based DNA tests as a global strategy for early detection - editorial.开创性的结直肠癌筛查：基于血液的DNA检测作为早期检测的全球策略——社论
Int J Surg. 2024 Nov 1;110(11):6906-6910. doi: 10.1097/JS9.0000000000001964.
2
Diagnostic test accuracy of nutritional tools used to identify undernutrition in patients with colorectal cancer: a systematic review.用于识别结直肠癌患者营养不良的营养评估工具的诊断测试准确性：一项系统综述
JBI Database System Rev Implement Rep. 2015 May 15;13(4):141-87. doi: 10.11124/jbisrir-2015-1673.
3
Cascade colorectal cancer screening guidelines: a global conceptual model.级联结直肠癌筛查指南：一个全球概念模型。
J Clin Gastroenterol. 2011 Apr;45(4):297-300. doi: 10.1097/MCG.0b013e3182098e07.
4
Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.基于愈创木脂的粪便潜血试验与粪便免疫化学试验用于一般风险人群结直肠癌筛查。
Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD009276. doi: 10.1002/14651858.CD009276.pub2.
5
Systematic review and meta-analysis of the evidence for flexible sigmoidoscopy as a screening method for the prevention of colorectal cancer.系统评价和荟萃分析显示，柔性乙状结肠镜检查作为结直肠癌预防的筛查方法具有一定的证据支持。
Br J Surg. 2012 Nov;99(11):1488-500. doi: 10.1002/bjs.8882. Epub 2012 Sep 21.
6
Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancer.循环肿瘤 DNA 甲基化 HAND1 基因：结直肠癌早期检测有前途的生物标志物。
BMC Med Genomics. 2024 Apr 30;17(1):117. doi: 10.1186/s12920-024-01893-9.
7
Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial.使用基于粪便DNA的SDC2甲基化检测进行结直肠癌筛查：一项多中心前瞻性试验。
BMC Gastroenterol. 2021 Apr 15;21(1):173. doi: 10.1186/s12876-021-01759-9.
8
Clinical Validation of a Circulating Tumor DNA-Based Blood Test to Screen for Colorectal Cancer.一种基于循环肿瘤DNA的血液检测用于筛查结直肠癌的临床验证
JAMA. 2025 Jun 2. doi: 10.1001/jama.2025.7515.
9
Screening for colorectal cancer using the faecal occult blood test, Hemoccult.使用便潜血试验（Hemoccult）筛查结直肠癌。
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD001216. doi: 10.1002/14651858.CD001216.pub2.
10
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.基于无细胞游离 DNA 的血液检测用于结直肠癌筛查。
N Engl J Med. 2024 Mar 14;390(11):973-983. doi: 10.1056/NEJMoa2304714.
本文引用的文献
1
Improving Noninvasive Colorectal Cancer Screening.改善非侵入性结直肠癌筛查
N Engl J Med. 2024 Mar 14;390(11):1045-1046. doi: 10.1056/NEJMe2400366.
2
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.基于无细胞游离 DNA 的血液检测用于结直肠癌筛查。
N Engl J Med. 2024 Mar 14;390(11):973-983. doi: 10.1056/NEJMoa2304714.
3
Screening for Colorectal Cancer: The Role of Clinical Laboratories.结直肠癌筛查：临床实验室的作用。
Clin Chem. 2024 Jan 4;70(1):150-164. doi: 10.1093/clinchem/hvad198.
4
Unraveling the potential clinical utility of circulating tumor DNA detection in colorectal cancer-evaluation in a nationwide Danish cohort.揭示循环肿瘤DNA检测在丹麦全国性队列的结直肠癌评估中的潜在临床应用价值。
Ann Oncol. 2024 Feb;35(2):229-239. doi: 10.1016/j.annonc.2023.11.009. Epub 2023 Nov 21.
5
Cost-Effectiveness of Blood-Based Biomarkers for Colorectal Cancer Screening-An Ounce of Prevention Is Worth a Pound of Cure.基于血液的生物标志物用于结直肠癌筛查的成本效益——预防为主，防重于治。
JAMA Netw Open. 2023 Nov 1;6(11):e2343346. doi: 10.1001/jamanetworkopen.2023.43346.
6
Cost-Effectiveness of Liquid Biopsy for Colorectal Cancer Screening in Patients Who Are Unscreened.液体活检用于未经筛查的结直肠癌患者筛查的成本效益。
JAMA Netw Open. 2023 Nov 1;6(11):e2343392. doi: 10.1001/jamanetworkopen.2023.43392.
7
High accuracy of a blood ctDNA-based multimodal test to detect colorectal cancer.基于血液中循环肿瘤DNA（ctDNA）的多模态检测对结直肠癌检测具有高准确性。
Ann Oncol. 2023 Dec;34(12):1187-1193. doi: 10.1016/j.annonc.2023.09.3113. Epub 2023 Oct 5.
8
Opportunities and Challenges in Screening for Colorectal Cancer.结直肠癌筛查的机遇与挑战。
Popul Health Manag. 2023 Aug;26(4):246-253. doi: 10.1089/pop.2023.0013. Epub 2023 Jul 26.
9
The Position of Circulating Tumor DNA in the Clinical Management of Colorectal Cancer.循环肿瘤DNA在结直肠癌临床管理中的地位
Cancers (Basel). 2023 Feb 17;15(4):1284. doi: 10.3390/cancers15041284.
10
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care?循环肿瘤DNA指导结直肠癌治疗：可作为标准治疗方案了吗？
Curr Treat Options Oncol. 2023 Feb;24(2):76-92. doi: 10.1007/s11864-022-01048-x. Epub 2023 Jan 19.
Zotero 插件